A new study reveals that shaming overweight or obese people does not help them lose weight and can do more harm.
‘Stress Responses to Discrimination’
The study, led by the researchers from University College London, analyzed nearly 3,000 adults aged 50 or older.
The participants were followed for more than four years. During that period, they were constantly asked if they felt they were discriminated due to their weight, age, gender or race.
The findings show that people being treated with disrespect over their size may even be more likely to put on a few pounds.
“Stress responses to discrimination can increase appetite, particularly for unhealthy, energy-dense food,” lead researcher Dr Sarah Jackson said in a statement. “Weight discrimination has also been shown to make people feel less confident about taking part in physical activity, so they tend to avoid it.”
Jackson and her team said that weight discrimination, commonly known as “fat shaming,” is part of the obesity problem and the solution.
The study aims to urge health professionals to be more supportive, as obese people may comfort eat as a result of being harassed by their weight.
A new study discovered that Alzheimer’s disease is likely to develop among those who have intensively taken a drug commonly prescribed for anxiety and insomnia.
Elderly people who have relied on common sedative called benzodiazepines are at higher risk of having the mind-robbing disorder.
The heavy use of the medication may cause or hasten the onset of Alzheimer’s.
“Our findings are of major importance for public health,” and warranted further investigation, said the team of researchers in France and Canada.”(…) A risk increase by 43-51 percent in users would generate a huge number of excess cases, even in countries where the prevalence of use of these drugs is not high.”
The study, published by the British Medical Journal, analyzed approximately 1,796 older people with Alzheimer’s disease.
Their health had been monitored for six years before the condition was diagnosed.
The researchers created an index that gauged the intensity of a person’s use of benzodiazepines. At the end of the study, the disease’s risk mounted steadily.
The findings strengthen the suspicions of medical experts, which is why more long-term research is needed to understand the link between benzodiazepines and Alzheimer’s disease.